305 results on '"Gandhi, Shipra"'
Search Results
2. Effect of neighborhood deprivation index on breast cancer survival in the United States
3. Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience
4. Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer
5. Tumor-associated mononuclear cells in the tumor bed of triple-negative breast cancer associate with clinical outcomes in the post-neoadjuvant chemotherapy setting
6. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer
7. Epidemiology of early vs. Late recurrence among women with Early-Stage estrogen Receptor-Positive breast cancer in the pathways study
8. Interaction between VEGF-A and immune checkpoint targets in triple-negative breast cancer and mechanisms of immune evasion and tumor progression.
9. Novel HLA-Ilo/HLA-IIhi phenotype and immune evasion in triple-negative breast cancer.
10. A phase II trial to assess the impact of β2 adrenergic blockade in immune checkpoint inhibitor (ICI)– refractory metastatic triple negative breast cancer (mTNBC).
11. Access to germline testing and prevalence of somatic mutations in patients with breast cancer from disadvantaged areas: A single-center study.
12. Lack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study
13. Left sided breast cancer is associated with aggressive biology and worse outcomes than right sided breast cancer
14. Development of a novel BRCAness score that predicts response to PARP inhibitors
15. Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis
16. UACA locus is associated with breast cancer chemoresistance and survival
17. Targeting the tumor microenvironment to improve clinical outcomes in triple negative breast cancer patients and bridge the current disparity gap.
18. Abstract A099: Preliminary pharmacodynamic characterization in patients with platinum-resistant ovarian cancer treated with nemvaleukin in combination with pembrolizumab
19. Cancer patients and COVID-19: Mortality, serious complications, biomarkers, and ways forward
20. Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer.
21. Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunity.
22. Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?
23. Association between Environmental Temperature and Survival in Gastroesophageal Cancers: A Population Based Study
24. Impact of Environmental Temperature on Clinical Outcomes and Tumor Microenvironment of Early-Stage Breast Cancer
25. Area Deprivation Index (ADI) among Patients with Breast Cancer in Buffalo
26. Real-world Analysis of Efficacy and Adverse Events for Advanced Triple Negative Breast Cancer (TNBC) treated with Immune Checkpoint Inhibitors (ICI): A Single Center Experience
27. Targeting beta-adrenergic receptor pathways in melanoma: how stress modulates oncogenic immunity
28. Racial and Ethnic Disparity in Preoperative Chemosensitivity and Survival in Patients With Early-Stage Breast Cancer
29. Neighborhood deprivation and race as predictors for cancer-related mortality in breast cancer.
30. 490 DiRECT Cohort: An NCORP longitudinal observational trial for disparities in results of immune checkpoint inhibitor treatment between Black and White cancer patients
31. 175 Metastatic triple negative breast cancer has distinct tumor immune landscape
32. Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx
33. Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies
34. Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy
35. Predictors of Complete Pathological Response with Chemoimmunotherapy in Triple-Negative Breast Cancer: A Meta-Analysis.
36. Association between Environmental Temperature and Survival in Gastroesophageal Cancers: A Population Based Study.
37. A 47-Year-Old Woman with Confusion and Weakness
38. Novel Biomarkers to Guide Immunotherapy De-Escalation in the Neoadjuvant Setting in Triple-Negative Breast Cancer
39. Oncotype Dx Score, HER2 Low Expression, and Clinical Outcomes in Early-Stage Breast Cancer: A National Cancer Database Analysis
40. Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
41. Contributors
42. Cardivascular Toxicities of Immunotherapy
43. Gastrointestinal Toxicities of Immunotherapy
44. Effect of Neighborhood Deprivation Index on Breast Cancer Survival in the United States
45. Abstract 919: Benefit of chemotherapy in early-stage breast cancer with variant histology
46. MEETING HIGHLIGHTS: THE THIRD MARIE SKŁODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.
47. Figure S1 from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
48. Table S1 from Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
49. Impact of Environmental Temperature on the Pathological Complete Response and Survival Outcomes of Breast Cancer: A NCDB and SEER study
50. Abstract PD1-04: Neighborhood Deprivation Index and Survival in Breast Cancer in the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.